HUE025576T2 - Combinations of pyrimidine-containing NNRTIs with RT inhibitors - Google Patents

Combinations of pyrimidine-containing NNRTIs with RT inhibitors Download PDF

Info

Publication number
HUE025576T2
HUE025576T2 HUE04787096A HUE04787096A HUE025576T2 HU E025576 T2 HUE025576 T2 HU E025576T2 HU E04787096 A HUE04787096 A HU E04787096A HU E04787096 A HUE04787096 A HU E04787096A HU E025576 T2 HUE025576 T2 HU E025576T2
Authority
HU
Hungary
Prior art keywords
combination
tmc278
pharmaceutically acceptable
acceptable salt
reverse transcriptase
Prior art date
Application number
HUE04787096A
Other languages
English (en)
Hungarian (hu)
Inventor
Paul Stoffels
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43778148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE025576(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of HUE025576T2 publication Critical patent/HUE025576T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE04787096A 2003-09-03 2004-09-03 Combinations of pyrimidine-containing NNRTIs with RT inhibitors HUE025576T2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US49977103P 2003-09-03 2003-09-03
EP03103275 2003-09-03
EP03103319 2003-09-08
EP03103335 2003-09-10
EP03103668 2003-10-02
US50848603P 2003-10-03 2003-10-03

Publications (1)

Publication Number Publication Date
HUE025576T2 true HUE025576T2 (en) 2016-04-28

Family

ID=43778148

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE04787096A HUE025576T2 (en) 2003-09-03 2004-09-03 Combinations of pyrimidine-containing NNRTIs with RT inhibitors

Country Status (9)

Country Link
KR (2) KR101638999B1 (es)
CN (1) CN102319433A (es)
DK (1) DK1663240T4 (es)
EA (1) EA014840B1 (es)
ES (1) ES2542017T5 (es)
HU (1) HUE025576T2 (es)
PT (1) PT1663240E (es)
SI (1) SI1663240T2 (es)
TW (1) TWI365744B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز

Also Published As

Publication number Publication date
ES2542017T5 (es) 2023-06-15
EA014840B1 (ru) 2011-02-28
KR101638999B1 (ko) 2016-07-12
DK1663240T4 (da) 2023-04-17
PT1663240E (pt) 2015-09-01
KR20110132475A (ko) 2011-12-07
TW200524612A (en) 2005-08-01
SI1663240T1 (sl) 2015-10-30
ES2542017T3 (es) 2015-07-29
CN102319433A (zh) 2012-01-18
SI1663240T2 (sl) 2023-05-31
KR20130127515A (ko) 2013-11-22
EA200600522A1 (ru) 2006-08-25
KR101539245B1 (ko) 2015-07-27
TWI365744B (en) 2012-06-11
DK1663240T3 (en) 2015-07-20

Similar Documents

Publication Publication Date Title
US20220008417A1 (en) Combinations of a pyrimidine containing nnrti with rt inhibitors
EP1159005B1 (en) Pharmaceutical combination of antiviral agents
DK1663240T3 (en) COMBINATIONS OF A PYRIMIDINE-CONTAINING NNRTI WITH RT INHIBITORS
ZA200601820B (en) Combinations of a pyrimidine containing NNRTI with RT inhibitors
Quinn et al. Overview of the genotypic findings from emtricitabine-treated HIV+ patients